Activist investor Starboard Value LP has acquired a significant 4.55% stake in Clearwater Analytics, purchasing 9,959,031 shares valued at $240.21 million. The investment in the cloud-based investment accounting software provider reflects confidence in its structural competitive advantages, including high switching costs and regulatory requirements that create sticky recurring revenue. However, the stock has underperformed the market by 26.7 percentage points over the past year.

Conagra Brands and Kimberly-Clark are presented as bargain investment opportunities despite significant stock declines over the past three years. Both companies have been pressured by inflation, leading to lower valuations and higher dividend yields. Conagra trades at 11x forward earnings with a 7.3% dividend yield, while Kimberly-Clark trades at 15x earnings with a 4.5% yield and a 54-year dividend increase streak. Kimberly-Clark's pending Kenvue acquisition is expected to drive future growth.

The article highlights three dividend stocks that have declined 20% or more from their 52-week highs and may present buying opportunities for long-term investors. Best Buy faces headwinds from slowing consumer spending and tariff uncertainty but offers a sustainable 5.9% dividend yield. Kimberly-Clark's planned $48.7 billion acquisition of Kenvue could drive future earnings growth and dividend increases despite initial market skepticism. Kraft Heinz, which paused its planned split, trades at attractive valuations with a 6.6% dividend yield and potential for upside if fundamentals improve.

Kimberly-Clark (KMB) is highlighted as an attractive dividend stock in 2026, offering a 4.7% yield and trading at a discounted 14.6x forward P/E ratio compared to sector peers. The company is a Dividend King with 54 consecutive years of dividend increases. While the consumer staples sector has surged 14.9% year-to-date, Kimberly-Clark remains undervalued relative to competitors like Walmart and Coca-Cola. The stock is positioned to benefit from its pending Kenvue acquisition, which is expected to deliver synergies and earnings growth.

Kenvue (KVUE) rose 2.55% to $18.88 after beating Q4 earnings expectations with adjusted EPS of $0.27 versus estimates of $0.22, prompting analysts to raise price targets. The company is proceeding with its $48.7 billion merger with Kimberly-Clark, expected to close in H2 2026, while implementing a restructuring that includes a 3.5% workforce reduction and $250 million in pre-tax charges for 2026.

Kenvue Inc. shares declined in premarket trading on Thursday with no specific news catalyst. The stock has fallen 15% over six months and is down 11.55% over the past year. The company's acquisition by Kimberly-Clark, approved by shareholders in January with 99% support, is expected to close in the second half of 2026. Technical analysis shows mixed momentum with overbought RSI at 73.07 but bullish MACD, suggesting a potential correction ahead. Analysts maintain a Hold rating with an average price target of $20.18.

Johnson & Johnson delivered solid Q4 2025 results with 9.1% revenue growth to $24.56 billion and improved profitability, driven by strong oncology and immunology demand. The company maintains its 'Dividend King' status with a 2.3-2.5% yield and strong balance sheet. Technically, the stock trades above key moving averages with bullish momentum, though a negative divergence suggests potential pullback. JNJ remains a defensive healthcare leader combining stable cash flows, innovation, and disciplined growth.

The article recommends Procter & Gamble and Johnson & Johnson as stable dividend stocks for uncertain market conditions. Both companies are Dividend Kings with 60+ years of consecutive dividend increases, strong cash flows, and resilient business models that perform well across economic cycles.

Coca-Cola, Kimberly-Clark, and Johnson & Johnson are recommended as Dividend Kings with 50+ years of consecutive dividend increases. These companies offer high-yielding dividends (2.5%-5%), strong financial profiles, and growth prospects through organic expansion and strategic acquisitions, making them suitable for passive income investors in 2026 and beyond.

Three stocks have attracted over $100 million in insider buying from prominent institutional investors: DoorDash (Sequoia Capital), Kenvue (Starboard Value LP), and Kymera Therapeutics (Baker Bros. Advisors). While these purchases signal confidence from sophisticated capital, investors should consider offsetting insider sales and the long-term viability of these bets.

Target Corporation presents a classic turnaround opportunity as activist hedge fund Toms Capital Investment Management builds a significant stake in the retailer. With the stock down 28% in 2025, Target trades at a low P/E ratio of 12-13x with a strong 4.6-5.0% dividend yield and 57 consecutive years of dividend increases. The timing is critical as new CEO Michael Fiddelke takes over on February 1, 2026, coinciding with activist pressure to drive operational improvements and unlock shareholder value.

Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches for several companies involved in merger and acquisition transactions.